Lack of prognostic significance for major adverse cardiac events of soluble suppression of tumorigenicity 2 levels in patients with ST-segment elevation myocardial infarction

BACKGROUND: Elevation of soluble suppression of tumorigenicity 2 (sST2) is associated with cardiac fibrosis and hypertrophy. Under investigation herein, was whether sST2 level is associated with major adverse cardiac events (MACE) and left ventricular (LV) remodeling after primary percutaneous coron...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Cardiol J
Hlavní autoři: Kim, Min, Lee, Dae In, Lee, Ju-Hee, Kim, Sang Min, Lee, Sang Yeub, Hwang, Kyung-Kuk, Kim, Dong-Woon, Cho, Myeong-Chan, Bae, Jang-Whan
Médium: Artigo
Jazyk:Inglês
Vydáno: Via Medica 2021
Témata:
Clinical Cardiology
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC8078943/
https://ncbi.nlm.nih.gov/pubmed/32104902
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5603/CJ.a2020.0028
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky